Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![ovtlyr Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1403154560781373441.png) ovtlyr [@ovtlyr](/creator/twitter/ovtlyr) on x XXX followers
Created: 2025-07-09 16:02:08 UTC

$GILD Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria announced on Wednesday that they have completed arrangements to provide a long-acting HIV prevention drug to low-income countries, even though they are not receiving funding from a major U.S. program designed to combat the global HIV/AIDS crisis.


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1942977581466402986/c:line.svg)

**Related Topics**
[countries](/topic/countries)
[$gild](/topic/$gild)
[gilead sciences](/topic/gilead-sciences)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/ovtlyr/status/1942977581466402986)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

ovtlyr Avatar ovtlyr @ovtlyr on x XXX followers Created: 2025-07-09 16:02:08 UTC

$GILD Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria announced on Wednesday that they have completed arrangements to provide a long-acting HIV prevention drug to low-income countries, even though they are not receiving funding from a major U.S. program designed to combat the global HIV/AIDS crisis.

XX engagements

Engagements Line Chart

Related Topics countries $gild gilead sciences stocks healthcare

Post Link

post/tweet::1942977581466402986
/post/tweet::1942977581466402986